The Benchmark Company
http://www.benchmarkcap.com/default.aspThe Benchmark Company, a full-service Broker Dealer, provides financial services to institutional and private clients. Its services include private placements, venture capital, M&A services, recapitalizations, divestitures & spin-offs, equity research as well as other financial services. The firm’s equity research division specializes in the media, energy, enterprise software, infrastructure software, and biotechnology & specialty pharmaceutical sectors.
-
Chicken Soup for the Soul Entertainment Announces Pricing of $21 Million of Notes Due 2025
-
VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock
-
Volitionrx Limited (VNRX) Prices 4.37M Share Common Stock Offering at $2.75/sh
-
VolitionRx Announces Pricing of Underwritten Public Offering of Common Stock
-
MTBC Completes Its Offering of Non-Convertible Preferred Stock with $20.7 Million in Gross Proceeds
-
MTBC Announces Upsizing and Pricing of $18.0 Million Public Offering of Preferred Stock
-
MTBC Announces Upsizing and Pricing of $18.0 Million Public Offering of Preferred Stock
-
MTBC Announces Commencement of Public Offering of Preferred Stock
-
MTBC Announces Commencement of Public Offering of Preferred Stock
-
VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriter
-
VolitionRx Limited Announces Closing of Public Offering of Common Stock
-
Volitionrx Limited (VNRX) Prices 2.25M Common Stock Offering at $5/Share
-
VolitionRx Limited Announces Pricing of Public Offering of Common Stock
-
Volitionrx Limited (VNRX) to Offer Common Stock
-
VolitionRx Limited Announces Proposed Public Offering of Common Stock
-
Volitionrx Limited (VNRX) Prices 2.5M Common Offering at $3.75/Share
